Genetic testing and referral patterns of non-BRCA mutation carriers at increased or uncertain risk of ovarian cancer.

被引：0
|
作者：
Lee, Sarah S. [1 ]
Baumann, Katherine [1 ]
Bhuptani, Bhoomi [1 ]
Turecamo, Sarah [1 ]
Smith, Julia Anne [1 ]
Pothuri, Bhavana [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1585
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Temporal Patterns and Adoption of Germline and Somatic BRCA Testing Ovarian Cancer.
    Lorenz, Judith
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2023, 83 (02)
  • [22] Increased risk of contralateral breast cancer for BRCA1 mutation carriers compared to BRCA2 mutation carriers
    Graeser, M.
    Engel, C.
    Zaino, M.
    Schmutzler, R.
    ONKOLOGIE, 2008, 31 : 28 - 28
  • [23] Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
    Ramus, Susan J.
    Antoniou, Antonis C.
    Kuchenbaecker, Karoline B.
    Soucy, Penny
    Beesley, Jonathan
    Chen, Xiaoqing
    McGuffog, Lesley
    Sinilnikova, Olga M.
    Healey, Sue
    Barrowdale, Daniel
    Lee, Andrew
    Thomassen, Mads
    HUMAN MUTATION, 2012, 33 (04) : 690 - 702
  • [24] Breast cancer outcomes after skin- and nipple-sparing mastectomy in BRCA pathogenic mutation carriers versus non-BRCA carriers
    Moshe, Nir
    Haisraely, Ory
    Globus, Ofer
    Faermann, Renata
    Abu-Shehada, Narmeen
    Anaby, Debbie
    Yam, Einav Gal
    Lahat, Nora Balint
    Galper, Shira
    Menes, Tehillah
    Haik, Josef
    Sklair-Levy, Miri
    Oedegaard, Cecille
    Kuehn, Thorsten
    Morrow, Monica
    Poortmans, Philip
    Bernstein-Molho, Rinat
    Kaidar-Person, Orit
    RADIOTHERAPY AND ONCOLOGY, 2025, 205
  • [25] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement
    Calonge, N
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (05) : 869 - 874
  • [26] Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility:: Recommendation statement
    Berg, AO
    Allan, JD
    Calonge, N
    Frame, PS
    Gordis, L
    Gregory, KD
    Harris, R
    Johnson, MS
    Klein, JD
    Loveland-Cherry, C
    Moyer, VA
    Ockene, JK
    Petitti, DB
    Siu, AL
    Teutsch, SM
    Yawn, BP
    ANNALS OF INTERNAL MEDICINE, 2005, 143 (05) : 355 - 361
  • [27] Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision
    Lewis, Kelsey E.
    Lu, Karen H.
    Klimczak, Amber M.
    Mok, Samuel C.
    CANCERS, 2018, 10 (02)
  • [28] Beyond BRCA: Patterns of risk-reducing surgery for non-BRCA, homologous recombination repair pathway gene variant carriers
    Lee, Sarah S.
    Karpel, Hannah C.
    Oh, Cheongeun
    Smith, Julia
    Pothuri, Bhavana
    GYNECOLOGIC ONCOLOGY, 2023, 170 : 234 - 240
  • [29] Breast cancer risk in BRCA mutation carriers after diagnosis of epithelial ovarian cancer is lower than in carriers without ovarian cancer
    Nanez, Andrea
    Stram, Douglas A.
    Powell, C. Bethan
    Garcia, Christine
    GYNECOLOGIC ONCOLOGY REPORTS, 2022, 39
  • [30] The HRAS1 minisatellite locus increases the risk of ovarian cancer in BRCA1 carriers, but not in BRCA2 carriers or sporadic ovarian cancer.
    Chu, W
    McLaughlin, J
    Phelan, C
    Cole, D
    Risch, H
    Narod, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) : 82 - 82
12345